Standard Postpartum Anti-D Dose
Administer 300 μg (1500 IU) of anti-D immune globulin intramuscularly within 72 hours of delivery to an unsensitized Rh-negative mother who delivers an Rh-positive infant. 1, 2
Dosing Protocol
The standard postpartum dose is:
- 300 μg (1500 IU) administered intramuscularly, preferably in the deltoid muscle 2
- Timing: Within 72 hours of delivery for optimal effectiveness 1, 2
- Never administer intravenously when using IM preparations 2
- Never administer to the neonate 2
Critical Timing Considerations
While 72 hours is the target window, delayed administration still provides benefit:
- Anti-D may still be given beyond 72 hours if the window is missed, as some protection is better than none 1, 2
- Administration up to 28 days postpartum is still recommended when the 72-hour window is missed 1
- The degree of protection decreases with delayed administration, but it remains preferable to no administration at all 1
Dose Modification for Large Fetomaternal Hemorrhage
One standard 300 μg dose covers up to 15 mL of fetal red blood cells (approximately 30 mL of fetal whole blood). 2, 3
When excessive fetomaternal hemorrhage is suspected:
- Perform quantitative testing (modified Kleihauer-Betke or flow cytometry) to determine the volume of fetal red cells in maternal circulation 2, 4
- Calculate additional doses: Divide the volume of fetal RBCs by 15 mL to determine the number of vials needed 2
- If the calculation results in a fraction, round up to the next whole number (e.g., if 1.4, give 2 vials) 2
- Additional dosing formula: Give 10 μg of anti-D for every additional 0.5 mL of fetal red blood cells beyond the initial 15 mL 1, 3
When to Suspect Large Fetomaternal Hemorrhage
Consider quantitative testing in these high-risk scenarios:
- Placental abruption 3
- Blunt abdominal trauma 3
- Manual removal of placenta 3
- Cesarean delivery 3
- Stillbirth 3
Special Circumstance: Recent Antenatal Dose
If delivery occurs within 3 weeks of the 28-week antenatal dose, the postpartum dose may be withheld unless there is evidence of fetomaternal hemorrhage exceeding 15 mL of red blood cells. 2 This recognizes that adequate anti-D levels may still be present from the recent antenatal administration.
Common Pitfalls to Avoid
- Do not skip postpartum anti-D even if the mother received antenatal prophylaxis at 28 weeks—both doses are required for optimal protection (reducing alloimmunization from 1.8% to 0.1-0.2%) 1
- Do not assume a standard dose is sufficient after traumatic delivery, cesarean section, or placental complications—always consider testing for excessive fetomaternal hemorrhage 3, 4
- Do not delay administration waiting for laboratory confirmation of infant blood type if it will exceed 72 hours—give anti-D empirically and it can be documented as unnecessary later if the infant is Rh-negative 1
- Do not confuse IM and IV preparations—verify the route specified on the product label, as IM products must never be given IV 2
Clinical Effectiveness
This two-dose protocol (28 weeks antenatal + postpartum) is highly effective: